Xuanwu Hospital,Capital Medical University
Beijing, Beijing Municipality, 100053, China
NCT Number: NCT06663163
The primary objective of this research is to study the effects of fever on seizure activity in patients with CDKL5 deficiency disorder
Looking for future studies?
Notify MeAll sexes
Observational
Beijing, Beijing Municipality, 100053, China
The survey aimed to gather information on seizure during and after fever and hot temperature bath therapy from families of children diagnosed with CDKL5 deficiency disorder through the WeChat group. It is expected to to develop new intervention strategies to reduce seizure frequency, improve patient quality of life, and ultimately address the therapeutic challenges faced by the global CDKL5 patient community.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This study was an observational study without intervention
Time frame: Fever episodes within one year leading up to 2 hours of questionnaire completion
The results of seizure reduction reported in the questionnaire completed by the parents or the seizure diary provided online
Xuanwu Hospital, Beijing
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06447675
Brain Diseases, CDKL5 Deficiency Disorder
Beijing, Beijing Municipality, China
View Trial DetailsNCT03572933
Brain Diseases, CDKL5 Deficiency Disorder
Phoenix, Arizona, United States
View Trial DetailsNCT07602205
Body Temperature Changes, Brain Diseases
View Trial DetailsNCT05064878
Brain Diseases, CDKL5 Deficiency Disorder
Birmingham, Alabama, United States
View Trial Details